A case of a Ewing sarcoma family tumor in the urinary bladder after treatment for acute lymphoblastic leukemia

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 12, 2007, Pages 841-844

  Osone, Shinya ^a,b   Hosoi, Hajime ^a,f   Tanaka, Kazushi ^a   Tsuchiya, Kunihiko ^a   Iehara, Tomoko ^a   Morimoto, Akira ^a,b   Hashida, Tetsuo ^b   Yamashita, Masuo ^b   Kawabata, Kenji ^c   Nishijo, Koichi ^d   Toguchida, Junya ^d   Hata, Jun Ichi ^e   Sugimoto, Tohru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Akashi Municipal Hospital   (Japan)

^c MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^f KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Ewing sarcoma family of tumors; EWS FLI1; Second malignant neoplasm; Urinary bladder

Indexed keywords

ANTIBODY; ASPARAGINASE; CD99 ANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PIRARUBICIN; PREDNISOLONE; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DYSURIA; ECHOGRAPHY; EWING SARCOMA; FOLLOW UP; HEMATURIA; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL CELL SARCOMA; SURGICAL TECHNIQUE; TRANSURETHRAL RESECTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COMBINED MODALITY THERAPY; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SARCOMA, EWING'S; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 37349002407     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318158155b     Document Type: Article

References (21)

1. Bernstein M, Kovar H, Paulussen M, et al. Ewing sarcoma family of tumors: Ewing sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2006:1002-1032.
2. Desai S. Primitive neuroectodermal tumour of the urinary bladder. Histopathology. 1998;32:477-478.
3. Banerjee SS, Eyden BP, McVey RJ, et al. Primitive peripheral neuroectodermal tumour of urinary bladder. Histopathology. 1997;30:486-490.
4. Gousse AE, Roth DR, Popek EJ, et al. Primary Ewing's sarcoma of the bladder associated with an elevated antinuclear antibody titer. J Urol. 1997;158:2265-2266.
5. Mentzel T, Flaschka J, Mentzel HJ, et al. Primary primitive neuroectodermal tumor of the urinary bladder. Clinicopathologic case report and differential small cell tumor diagnosis of this site. Pathologe. 1998;19:154-158.
6. Colecchia M, Dagrada GP, Poliani PL, et al. Immunophenotypic and genotypic analysis of a case of primary peripheral primitive neuroectodermal tumour (pPNET) of the urinary bladder. Histopathology. 2002;40:108-109.
7. Krüger S, Schmidt H, Kausch I, et al. Primitive neuroectodermal tumor (PNET) of the urinary bladder. Pathol Res Pract. 2003;199:751-754.
8. Lopez-Beltran A, Pérez-Seoane C, Montironi R, et al. Primary primitive neuroectodermal tumour of the urinary bladder: a clinicopathological study emphasizing immunohistochemical, ultrastructural and molecular analyses. J Clin Pathol. 2006;59:775-778.
9. Spunt SL, Rodriguez-Galindo C, Fuller CE, et al. Ewing sarcoma-family tumors that arise after treatment of primary childhood cancer. Cancer. 2006;107:201-206.
10. Henderson TO, Whitton J, Stovall M, et al. Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2007;99:300-308.
11. Loning L, Zimmermann M, Reiter A, et al. Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood. 2000;95:2770-2775.
12. Bhatia S, Sather HN, Pabustan OB, et al. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood. 2002;99:4257-4264.
13. Hijiya N, Hudson MM, Lensing S, et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA. 2007;297:1207-1215.
14. Kim GE, Beach B, Gastier-Foster JM, et al. Ewing sarcoma as a second malignant neoplasm after acute lymphoblastic leukemia. Pediatr Blood Cancer. 2005;45:57-59.
15. Morimoto A, Kuriyama K, Hibi S, et al. Prognostic value of early response to treatment combined with conventional risk factors in pediatric acute lymphoblastic leukemia. Int J Hematol. 2005;81:228-234.
16. Zucman J, Melot T, Desmaze C, et al. Combinatorial generation of variable fusion proteins in the Ewing family tumours. EMBO J. 1993;12:4481-4487.
17. Kushner BH, Meyers PA, Gerald WL, et al. Very high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. J Clin Oncol. 1995;13:2796-2804.
18. Dahm P, Gschwend JE. Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol. 2003;44:672-681.
19. Fritsch MK, Bridge JA, Schuster AE, et al. Performance characteristics of a reverse transcriptase-polymerase chain reaction assay for the detection of tumor-specific fusion transcripts from archival tissue. Pediatr Devel Pathol. 2002;6:43-53.
20. Hisaoka M, Tsuji S, Morimitsu Y, et al. Molecular detection of EWS-FLI1 chimeric transcripts in Ewing family tumors by nested reverse transcription-polymerase chain reaction: application to archival paraffin-embedded tumor tissues. APMIS. 1999;107:577-584.
21. Travis LB, Curtis RE, Glimelius B, et al. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst. 1995;87:524-530.